当前位置:首页 - 行情中心 - 华东医药(000963) - 财务分析

华东医药

(000963)

  

流通市值:573.77亿  总市值:574.89亿
流通股本:17.51亿   总股本:17.54亿

华东医药(000963)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润8.60亿元,每股收益0.49元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益2248779.32万元,未分配利润1655636.31万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产3446784.43万元,负债1198005.10万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入10,410,809,128.7240,623,782,520.4330,394,530,509.5120,385,344,288.81
营业总成本9,331,357,509.9237,081,915,122.9127,539,505,233.918,443,622,876.24
营业利润1,072,095,809.873,452,927,218.732,708,572,838.61,798,460,883.53
利润总额1,068,188,799.353,465,985,765.122,688,109,670.731,785,135,155.34
净利润860,245,520.892,846,396,949.972,193,548,822.361,439,855,714.43
其他综合收益40,589,535.150,506,468.03-3,888,970.61-8,889,448.01
综合收益总额900,835,055.992,896,903,4182,189,659,851.751,430,966,266.42
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计19,212,283,494.618,496,680,369.9419,587,988,033.0918,728,856,472.85
非流动资产合计15,255,560,785.7715,012,681,447.0414,404,697,476.3914,227,143,743.21
资产总计34,467,844,280.3733,509,361,816.9833,992,685,509.4832,956,000,216.06
流动负债合计10,918,317,841.2610,802,606,090.1911,643,411,900.1311,358,018,205.41
非流动负债合计1,061,733,194.191,124,491,000.691,410,089,498.231,414,973,512.1
负债合计11,980,051,035.4511,927,097,090.8813,053,501,398.3612,772,991,717.51
归属于母公司股东权益合计21,955,243,888.921,047,609,756.6620,298,210,883.6619,532,395,598.16
股东权益合计22,487,793,244.9221,582,264,726.120,939,184,111.1220,183,008,498.55
负债和股东权益合计34,467,844,280.3733,509,361,816.9833,992,685,509.4832,956,000,216.06
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计10,079,165,831.3144,170,157,818.4133,330,003,956.9822,779,476,575.4
经营活动现金流出小计10,563,688,497.4440,240,941,111.7131,080,726,073.1720,757,732,826.75
经营活动产生的现金流量净额-484,522,666.133,929,216,706.72,249,277,883.812,021,743,748.65
投资活动现金流入小计5,328,201.94243,482,795.78225,228,902.82230,301,405.8
投资活动现金流出小计712,704,326.831,994,034,738.291,173,150,395.68807,988,433.22
投资活动产生的现金流量净额-707,376,124.89-1,750,551,942.51-947,921,492.86-577,687,027.42
筹资活动现金流入小计1,572,503,524.845,099,369,770.654,354,909,040.172,606,267,337.21
筹资活动现金流出小计1,501,007,257.356,492,731,116.635,573,224,030.053,532,758,944.76
筹资活动产生的现金流量净额71,496,267.49-1,393,361,345.98-1,218,314,989.88-926,491,607.55
汇率变动对现金及现金等价物的影响17,392,454.165,945,890.37-20,487,569.218,950,719.04
现金及现金等价物净增加额-1,103,010,069.37791,249,308.5862,553,831.86526,515,832.72
期末现金及现金等价物余额3,105,149,941.544,208,160,010.913,479,464,534.193,943,426,535.05
最新报告期:2024-04-28
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
国泰君安丁丹,吴晗1.932.292.662024-04-28
中金公司全芳,朱言音1.852.06--2024-04-28
西部证券李雯,李梦园2.002.252.592024-04-26
信达证券刘嘉仁,周子莘1.932.232.482024-04-26
中国银河孙怡,程培1.912.252.632024-04-26
TOP↑